These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24983500)

  • 1. TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy.
    Costanzo A; Pediconi N; Narcisi A; Guerrieri F; Belloni L; Fausti F; Botti E; Levrero M
    FEBS Lett; 2014 Aug; 588(16):2590-9. PubMed ID: 24983500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p73 in apoptosis.
    Stiewe T; Pützer BM
    Apoptosis; 2001 Dec; 6(6):447-52. PubMed ID: 11595834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p73 as a pharmaceutical target for cancer therapy.
    Bisso A; Collavin L; Del Sal G
    Curr Pharm Des; 2011; 17(6):578-90. PubMed ID: 21391908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The coordinated interaction of multifunctional members of p53 family determines many key processes in multicellular organisms].
    Vilgelm AE; Zaika AI; Prasolov VS
    Mol Biol (Mosk); 2011; 45(1):180-97. PubMed ID: 21485507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From p63 to p53 across p73.
    Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G
    FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p73 and p63: why do we still need them?
    Blandino G; Dobbelstein M
    Cell Cycle; 2004 Jul; 3(7):886-94. PubMed ID: 15254416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53 family members and human cancers.
    Bénard J; Douc-Rasy S; Ahomadegbe JC
    Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic prospects for p73 and p63: rising from the shadow of p53.
    Vilgelm A; El-Rifai W; Zaika A
    Drug Resist Updat; 2008; 11(4-5):152-63. PubMed ID: 18801697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How the TP53 family proteins TP63 and TP73 contribute to tumorigenesis: regulators and effectors.
    Candi E; Agostini M; Melino G; Bernassola F
    Hum Mutat; 2014 Jun; 35(6):702-14. PubMed ID: 24488880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo.
    Venkatanarayan A; Raulji P; Norton W; Chakravarti D; Coarfa C; Su X; Sandur SK; Ramirez MS; Lee J; Kingsley CV; Sananikone EF; Rajapakshe K; Naff K; Parker-Thornburg J; Bankson JA; Tsai KY; Gunaratne PH; Flores ER
    Nature; 2015 Jan; 517(7536):626-30. PubMed ID: 25409149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach?
    Zawacka-Pankau J; Kostecka A; Sznarkowska A; Hedström E; Kawiak A
    Cell Cycle; 2010 Feb; 9(4):720-8. PubMed ID: 20160513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73.
    Zdzalik M; Pustelny K; Kedracka-Krok S; Huben K; Pecak A; Wladyka B; Jankowski S; Dubin A; Potempa J; Dubin G
    Cell Cycle; 2010 Nov; 9(22):4584-91. PubMed ID: 21088494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of p73 in malignancy: tumor suppressor or oncogene?
    Stiewe T; Pützer BM
    Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of p53 with prolyl isomerases: Healthy and unhealthy relationships.
    Mantovani F; Zannini A; Rustighi A; Del Sal G
    Biochim Biophys Acta; 2015 Oct; 1850(10):2048-60. PubMed ID: 25641576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulating the genome surveillance system: miRNAs and the p53 super family.
    Bailey SG; Sanchez-Elsner T; Stephanou A; Cragg MS; Townsend PA
    Apoptosis; 2010 May; 15(5):541-52. PubMed ID: 20091234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
    Boominathan L
    Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site.
    Orzol P; Holcakova J; Nekulova M; Nenutil R; Vojtesek B; Coates PJ
    Histol Histopathol; 2015 May; 30(5):503-21. PubMed ID: 25510918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.